Embecta Corp.
Company Stats
- Market Cap
- $320.7M
- as of Sep 30, 2026
- Enterprise Value
- $1.5B
- Shares Outstanding
- 56.7M
- Free Float
- 98.6%
Income Statement
- Revenue
- $1.1B
- Operating Income
- $242.1M
- Net Income
- $95.4M
- EBITDA
- $282.8M
- Revenue Growth, 3Y
- -1.5%
- FCF Margin, 3Y Avg
- 7.4%
- FCF Margin, Worst Year
- 1.8%
Cash Flow
- Free Cash Flow
- $182.4M
- FCF Yield
- 56.9%
- Owner FCF Yield
- 47.0%
Balance Sheet
- Cash & Equivalents
- $225.5M
- Total Debt
- $1.4B
- Net Debt
- $1.2B
- Net Debt / EBITDA
- 4.21x
- EV / EBITDA
- 5.35x
- Net Debt / EBIT
- 4.92x
Returns & Capital
- Dividends Paid
- $35.0M
- Dividend Yield
- 10.9%
- Dividend Payout, 3Y Avg
- 43.2%
- SBC, 3Y Avg
- $26.5M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $1.1B | $182.4M | 16.9% |
| FY2024 | $1.1B | $19.9M | 1.8% |
| FY2023 | $1.1B | $41.2M | 3.7% |
| FY2022 | $1.1B | $388.6M | 34.4% |
| FY2021 | $1.2B | $419.5M | 36.0% |
Annual filing data through FY ended September 30, 2025; shares and float as of October 6, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Earnings
Other Coverage
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Insider Signal
Chemours and Chiron Lead Weekly Insider Buying Clusters
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
July 4, 2026
Guidance Season
Chipmakers Lead a Guidance Season Almost Free of Cuts
Stronger demand supports expansion as pricing diverges
August 14, 2026
Insider Signal
Chemours and Chiron Lead Weekly Insider Buying Clusters
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
July 4, 2026
Guidance Season
Chipmakers Lead a Guidance Season Almost Free of Cuts